宋城演藝(300144.SZ):擬繼續使用不超15億元閒置自有資金進行證券及理財產品投資
格隆匯6月21日丨宋城演藝(300144.SZ)公佈,公司於2021年6月21日召開的第七屆董事會第十一次會議審議通過了《關於使用閒置自有資金投資證券及理財產品的議案》,同意公司在確保資金安全、操作合法合規、保證正常生產經營不受影響的前提下,繼續使用閒置自有資金進行證券及理財產品投資,使閒置資金在確保安全性、流動性的基礎上實現保值增值,額度不超過人民幣15億元,在此限額內資金可以滾動使用,使用期限為自董事會審議通過之日起2年內有效,並授權公司管理層在該額度範圍內行使投資決策權,簽署相關法律文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.